BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 865 filers reported holding BAXTER INTL INC in Q3 2016. The put-call ratio across all filers is 0.50 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $760,000 | +196.9% | 12,556 | +154.4% | 0.02% | +200.0% |
| Q1 2017 | $256,000 | -77.7% | 4,936 | -81.0% | 0.01% | -75.0% |
| Q4 2016 | $1,149,000 | +56.5% | 25,916 | +68.0% | 0.03% | +64.7% |
| Q3 2016 | $734,000 | +95.2% | 15,430 | +85.7% | 0.02% | +112.5% |
| Q2 2016 | $376,000 | -88.2% | 8,311 | -89.3% | 0.01% | -91.1% |
| Q1 2016 | $3,196,000 | +302.5% | 77,791 | +273.8% | 0.09% | +542.9% |
| Q4 2015 | $794,000 | -63.9% | 20,812 | -68.9% | 0.01% | -61.1% |
| Q3 2015 | $2,198,000 | +27.5% | 66,901 | +171.3% | 0.04% | +16.1% |
| Q2 2015 | $1,724,000 | +414.6% | 24,655 | +404.2% | 0.03% | +342.9% |
| Q1 2015 | $335,000 | -57.4% | 4,890 | -54.4% | 0.01% | -46.2% |
| Q4 2014 | $786,000 | +2.2% | 10,726 | +0.1% | 0.01% | -13.3% |
| Q3 2014 | $769,000 | -50.1% | 10,718 | -49.7% | 0.02% | -37.5% |
| Q2 2014 | $1,540,000 | -44.3% | 21,299 | -43.3% | 0.02% | -31.4% |
| Q1 2014 | $2,764,000 | -46.9% | 37,558 | -49.8% | 0.04% | -38.6% |
| Q4 2013 | $5,202,000 | +28.0% | 74,806 | +20.9% | 0.06% | +9.6% |
| Q3 2013 | $4,065,000 | – | 61,879 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 298,721 | $23,969,000 | 8.70% |
| GENERATION INVESTMENT MANAGEMENT LLP | 17,424,560 | $1,398,147,000 | 6.24% |
| Soditic Asset Management LLP | 77,950 | $6,255,000 | 6.24% |
| Veritas Asset Management LLP | 11,110,132 | $891,477,000 | 5.32% |
| Dash Acquisitions Inc. | 84,560 | $6,785,000 | 4.74% |
| Prosight Management, LP | 121,075 | $9,715,000 | 4.49% |
| TSFG, LLC | 94,977 | $7,621,000 | 4.07% |
| CINCINNATI FINANCIAL CORP | 1,344,648 | $107,895,000 | 2.93% |
| Dundas Partners LLP | 204,535 | $19,304,000 | 2.82% |
| Unified Trust Company, N.A. | 59,491 | $4,689,000 | 2.72% |